TREA

79349187 - DXT

Follow

Information

  • Trademark
  • 79349187
  • Serial Number
    79349187
  • Registration Number
    7245080
  • Filing Date
    April 12, 2022
    2 years ago
  • Registration Date
    December 19, 2023
    a year ago
  • Transaction Date
    December 31, 2024
    a month ago
  • Status Date
    December 19, 2023
    a year ago
  • Published for Opposition Date
    October 03, 2023
    a year ago
  • Location Date
    December 19, 2023
    a year ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    YOO, JEANE
  • Attorney Docket Number
    109769.00081
    Attorney Name
    Theodore R. Remaklus
    Law Office Assigned Location Code
    N20
  • Owners
Information
Mark Drawing Code
4
Mark Identification
DXT
Case File Statements
  • GS0091: Downloadable computer software for use in identifying new drugs; downloadable computer software for use by doctors and other medical professionals in capturing, tracking, reporting, analyzing health data for use in making informed medical decisions; downloadable virtual reality software for medical teaching; downloadable virtual reality software for medical screening; downloadable computer software platforms for use in database management in the field of medicine; downloadable computer application software for mobile phones, namely, software for use in identifying new drugs; downloadable computer software using artificial intelligence for use in identifying new drugs; none of the foregoing for use with blood-related cell processing devices, blood-related medical and laboratory devices, blood-related software and technology, or blood-related medical device and data management systems
  • GS0051: Pharmaceutical preparation for the treatment of respiratory diseases; pharmaceutical preparation for the treatment of bone diseases; analgesic and muscle relaxant pharmaceutical preparations; antibacterial pharmaceuticals; anti-epileptic pharmaceutical preparations; balms for pharmaceutical purposes; capsules sold empty for pharmaceuticals; cardiovascular pharmaceutical preparations; ocular pharmaceuticals; pharmaceutical products for ophthalmological use; pharmaceutical preparations for ocular or intraocular surgery; pharmaceutical preparations for treating allergic rhinitis and asthma; pharmaceutical preparations for the prevention and treatment of rare ocular disorders or diseases; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases; pharmaceutical antitussive cold preparations; pharmaceutical preparations for use in chemotherapy; pharmaceutical products for the treatment of viral and infectious diseases; pharmaceutical products for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in the treatment of rare tissue and organ transplantation-related diseases and conditions; pharmaceutical preparations for use in tissue and organ transplantation; pharmaceutical preparations, namely, anticoagulants; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for peripheral nervous system; pharmaceutical preparations for the treatment of rare diabetes-related conditions; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for the treatment of bacteria-based diseases; pharmaceutical preparations, namely, antiviral preparations, antibiotics, antifungal preparations and vaccines; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations, namely, an analgesic for human consumption taken orally; disinfectants for hygiene purposes; none of the foregoing for use with blood-related cell processing devices, blood-related medical and laboratory devices, blood-related software and technology, or blood-related medical device and data management systems for peripheral nervous system; pharmaceutical preparations for the treatment of rare diabetes-related conditions; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for the treatment of bacteria-based diseases; pharmaceutical preparations, namely, antiviral preparations, antibiotics, antifungal preparations and vaccines; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations, namely, an analgesic for human consumption taken orally; disinfectants for hygiene purposes; none of the foregoing for use with blood-related cell processing devices, blood-related medical and laboratory devices, blood-related software and technology, or blood-related medical device and data management systems
  • GS0421: Software as a service (SAAS) services featuring software using artificial intelligence for use in identifying new drugs; providing a website featuring non-downloadable software using artificial intelligence for use in identifying new drugs; research in the field of artificial intelligence; design and development of computer software in the field of medicine; design and development of virtual reality software for medical screening; design and development of virtual reality software for medical teaching, none of the foregoing for use with blood-related cell processing devices, blood-related medical and laboratory devices, blood-related software and technology, or blood-related medical device and data management systems
Case File Event Statements
  • 9/8/2022 - 2 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 9/9/2022 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 9/13/2022 - 2 years ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 1/30/2023 - 2 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 2/3/2023 - 2 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 2/4/2023 - 2 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 3/29/2023 - a year ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 3/29/2023 - a year ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 4/20/2023 - a year ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 8/3/2023 - a year ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 8/3/2023 - a year ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 8/3/2023 - a year ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 8/30/2023 - a year ago
    13 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 9/13/2023 - a year ago
    16 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 9/13/2023 - a year ago
    14 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 9/13/2023 - a year ago
    15 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 10/3/2023 - a year ago
    17 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 10/3/2023 - a year ago
    18 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 10/4/2023 - a year ago
    19 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 12/19/2023 - a year ago
    21 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 12/19/2023 - a year ago
    20 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 3/19/2024 - 10 months ago
    22 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 3/29/2024 - 10 months ago
    23 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 3/29/2024 - 10 months ago
    24 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 4/23/2024 - 9 months ago
    25 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 12/26/2024 - a month ago
    27 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 12/26/2024 - a month ago
    29 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 12/26/2024 - a month ago
    26 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 12/26/2024 - a month ago
    28 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 12/26/2024 - a month ago
    30 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA